RED-BLOOD-CELL HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY MEASURED USING 6-MERCAPTOPURINE AS A SUBSTRATE - A POPULATION STUDY IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA

被引:26
作者
LENNARD, L [1 ]
HALE, JP [1 ]
LILLEYMAN, JS [1 ]
机构
[1] UNIV SHEFFIELD,CHILDRENS HOSP,DEPT PAEDIAT,PAEDIAT HAEMATOL SECT,SHEFFIELD S10 2TH,ENGLAND
关键词
ACUTE LYMPHOBLASTIC LEUKEMIA; 6-MERCAPTOPURINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RED BLOOD CELLS;
D O I
10.1111/j.1365-2125.1993.tb00365.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 6-Mercaptopurine (6-MP) is used in the continuing chemotherapy of childhood acute lymphoblastic leukaemia. The formation of red blood cell (RBC) 6-thioguanine nucleotide (6-TGN) active metabolites, not the dose of 6-MP, is related to cytotoxicity and prognosis. But there is an apparent sex difference in 6-MP metabolism. Boys require more 6-MP than girls to produce the same range of 6-TGN concentrations. Given the same dose, they experience fewer dose reductions because of cytotoxicity, and have a higher relapse rate. 2 The enzyme hypoxanthine phosphoribosyltransferase (HPRT) catalyses the initial activation step in the metabolism of 6-MP to 6-TGNs, a step that requires endogenous phosphoribosyl pyrophosphate (PRPP) as a cosubstrate. Both HPRT and the enzyme responsible for the formation of PRPP are X-linked. 3 RBC HPRT activity was measured in two populations, 86 control children and 63 children with acute lymphoblastic leukaemia. 6-MP was used as the substrate and the formation of the nucleotide product, 6-thioinosinic acid (TIA) was measured. RBC 6-TGN concentrations were measured in the leukaemic children at a standard dose of 6-MP. 4 There was a 1.3 to 1.7 fold range in HPRT activity when measured under optimal conditions. The leukaemic children had significantly higher HPRT activities than the controls (median difference 4.2 mumol TIA ml-1 RB Cs h-1, 95 % C. I. 3.7 to 4.7, P < 0.0001). In the leukaemic children HPRT activity (range 20.4 to 26.6 mumol TIA ml-1 RBCs h-1, median 23.6) was not related to the production of 6-TGNs (range 60 to 1,024 pmol 8 x 10(-8) RBCs, median 323). RBC HPRT was present at a high activity even in those children with low 6-TGN concentrations. 5 When HPRT is measured under optimal conditions it does not appear to be the metabolic step responsible for the observed sex difference in 6-MP metabolism. This may be because RBC HPRT activity is not representative of other tissues but it could equally be because other sex-linked factors are influencing substrate availability.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 36 条
[1]   DEVELOPMENTAL-CHANGES IN PURINE PHOSPHORIBOSYLTRANSFERASES IN HUMAN AND RAT TISSUES [J].
ADAMS, A ;
HARKNESS, RA .
BIOCHEMICAL JOURNAL, 1976, 160 (03) :565-576
[2]  
BERMAN PAM, 1990, J BIOL CHEM, V265, P6562
[3]   SEQUENCE-DEPENDENT, TIME-DEPENDENT AND DOSE-DEPENDENT SYNERGISM OF METHOTREXATE AND 6-MERCAPTOPURINE IN MALIGNANT HUMAN T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
BAKKER, MAH ;
HULSCHER, TW ;
DEABREU, RRA ;
SCHRETLEN, EDAM ;
VANLAARHOVEN, JPRM ;
DEBRUYN, CHMM .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) :3549-3555
[4]   DOSE-RELATED EFFECTS OF METHOTREXATE ON PURINE AND PYRIMIDINE NUCLEOTIDES AND ON CELL-KINETIC PARAMETERS IN MOLT-4 MALIGNANT HUMAN T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
DEABREU, RA ;
BAKKER, MAH ;
HULSCHER, TW ;
VANBAAL, JM ;
DEVAAN, GAM .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) :3557-3564
[5]  
BUESAPEREZ JM, 1980, CANCER RES, V40, P139
[6]   ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM [J].
CADMAN, E ;
HEIMER, R ;
DAVIS, L .
SCIENCE, 1979, 205 (4411) :1135-1137
[7]   ABNORMAL PURINE METABOLISM AND PURINE OVERPRODUCTION IN A PATIENT DEFICIENT IN PURINE NUCLEOSIDE PHOSPHORYLASE [J].
COHEN, A ;
DOYLE, D ;
MARTIN, DW ;
AMMANN, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (26) :1449-1454
[8]  
DAVIDSON BL, 1991, AM J HUM GENET, V48, P951
[9]   VARIABLE MERCAPTOPURINE METABOLISM IN CHILDREN WITH LEUKEMIA - A PROBLEM OF NONCOMPLIANCE [J].
DAVIES, HA ;
LENNARD, L ;
LILLEYMAN, JS .
BRITISH MEDICAL JOURNAL, 1993, 306 (6887) :1239-1240
[10]  
GARDNER MJ, 1989, STATISTICS CONFIDENC